Israel has moved quickly. A notice issued by Ben Gurion Airport on June 10 bars citizens and residents of Kenya, Uganda, Rwanda, South Sudan, and the Democratic Republic of Congo from boarding any flights to Israel. It goes further: any foreigner who visited any of those five countries in the past 21 days is also barred from travel, regardless of nationality.
The measure is a direct response to a Bundibugyo Ebola outbreak that began in the DRC’s Ituri province in early May 2026 and has since crossed into Uganda, where 19 cases have been recorded. The World Health Organization declared a public health emergency on May 17, and several countries have since begun tightening their borders.
Where the Outbreak Stands
Bundibugyo Ebola is a strain distinct from the better-known Zaire strain that caused the 2014–2016 West Africa crisis. It is still dangerous but historically associated with lower fatality rates. The current outbreak’s origin point is Ituri Province in northeastern DRC, a region with a history of instability and limited health infrastructure.
From Ituri, the virus crossed into Uganda, where authorities have confirmed 19 cases. Uganda has dealt with Ebola before and has a relatively experienced public health response system. Rwanda, Kenya, and South Sudan have so far reported no confirmed cases, though their proximity to the affected zones has placed them on regional watchlists.
Kenya: Caught in a Regional Net
The frustration in Kenya is understandable. Not a single Ebola case has been reported inside the country’s borders. And yet, Kenyan travelers and tourists bound for Israel now face the same restrictions as citizens of DRC, where the virus originated.
For a country that has worked hard to position Nairobi as East Africa’s premier gateway—for business, tourism, and international conferences—being grouped into a blanket travel ban carries real economic weight. Tourism operators, airlines, and hospitality businesses have voiced concern over the reputational spillover, which can outlast the restrictions themselves.
“Zero cases. Zero risk from our side. But the damage to our tourism reputation starts the moment a travel ban is announced.”
Israel Is Not Alone
Israel’s move is not an outlier. Similar precautionary restrictions have been introduced by the United States and Canada, both citing regional mobility concerns in East and Central Africa. The logic is consistent: because the five affected or adjacent countries share porous borders and significant cross-border movement, virus containment cannot be assumed within national lines alone.
Public health officials have long debated the effectiveness of travel bans during outbreaks. Critics argue they drive cases underground, discourage reporting, and damage the economies of countries that may have done nothing wrong. Proponents say that when a WHO emergency is declared and transmission is still active, caution at the border is a basic duty of care to domestic populations.
What Travelers Should Know
The 21-day window in Israel’s notice aligns with the maximum incubation period for Ebola, which makes it a standard benchmark in outbreak response protocols. Anyone who has been in Kenya, Uganda, Rwanda, South Sudan, or DRC within that window is currently unable to board a flight to Israel, regardless of whether they showed any symptoms or came into contact with affected areas.
Travelers with upcoming itineraries should check directly with their airlines and the Israeli embassy or consulate in their country for the most current guidance. Restrictions of this nature can be lifted as quickly as they are imposed, depending on how the outbreak trajectory develops over the coming weeks.
The Bundibugyo outbreak is a reminder that in a highly connected region, a health crisis in one country rarely stays contained within its borders for long—and that the economic and diplomatic consequences of outbreak response reach far beyond the epicentre. For Kenya, the challenge now is to make its zero-case status visible loudly enough to limit the collateral damage.
Stay updated with official guidance from the WHO and your country’s health ministry.
